Each year, 25,000 Canadians hear the words, ‘you have dementia.’ But dementia is more than just numbers. Friends, families and members of our communities all experience the personal and social impact of dementia. For our health-care system and economy this means higher demand for services and soaring costs. It’s not just their disease. It’s ours too.
That’s why the Alzheimer Society is asking Canadians to be #InItForAlz and support vital research to eliminate this disease and its impact on Canadians. Through this campaign, the Alzheimer Society also hopes to change the dialogue about a disease that continues to be shrouded in silence.
Dementia doesn’t discriminate and can affect anyone. It’s one of the fastest-growing diseases of our time, but still has no cure or effective treatments. It can only be beat if everyone takes action.
You, too, can be #InItForAlz and make a difference right from your computer. Visit alzheimer.ca/initforalz to watch a video about the personal stories of Canadians impacted by dementia, and donate to support research. You can also use the hashtag #InItForAlz to spread the word that “it’s not just their disease. It’s ours too.”
Right now, an estimated 564,000 Canadians are living with dementia, with 15,000 in York Region.
In 15 years, this figure will increase by 66%, to 937,000 in Canada; 110%, to 31,500 in York Region.
Over 2,200 families turned to the Alzheimer Society of York Region for help in 2016.
For every person with dementia, one or more caregivers provide care.
Dementia doesn’t define a person. They’re still the same individual as they were before their diagnosis.
People with dementia can continue the things they love and remain active in their communities with the right help and support.
Alzheimer Societies across Canada provide programs and support services to help people with all forms of dementia, including Alzheimer’s disease, and their caregivers to live as well as possible.
The Alzheimer Society is a leading Canadian funder of dementia research. Since 1989, it has invested over $50 million in bio-medical and quality-of-life research through its Alzheimer Society Research Program.